The massive warrant overhang (over 3.4M shares, including 2.27M at $5.29) combined with a going-concern warning and a $12M market cap creates a structurally bearish setup. Monitor for any 424B prospectus supplements indicating actual selling by the selling stockholders, which would add immediate supply. The stock's ability to absorb further dilution without a fundamental catalyst (e.g., Pivot pump revenue traction) is limited.
Price Chart
Executive Summary
Modular Medical filed an S-3 registration statement to register 193,027 shares of common stock for resale by selling stockholders, primarily shares issuable upon exercise of warrants from a September 2025 inducement and December 2025 underwriter warrants, plus 52,000 shares issued to service providers. The company will not receive proceeds from the resale but could receive up to ~$3.2 million from cash warrant exercises. This is a routine contractual registration with no new primary offering, but the filing adds to a heavy overhang of outstanding warrants (over 3.4M shares) on a $12M market cap, and the auditor's report includes a going-concern paragraph, signaling persistent capital needs.
Key Facts
- S-3 registers 193,027 shares for resale by selling stockholders (108,372 warrant shares, 32,655 underwriter warrant shares, 52,000 service provider shares).
- Company receives no proceeds from resale; could receive up to ~$3.2M from cash warrant exercises at $25.20 and $13.86 per share.
- Outstanding shares: 5,984,242 as of July 31, 2026; post-offering would be 6,125,269 assuming full warrant exercise.
- Total outstanding warrants: over 3.4M shares at various exercise prices, including 2,269,933 at $5.29, creating massive potential dilution.
- Auditor's report includes a going-concern explanatory paragraph, indicating substantial doubt about the company's ability to continue.
- Stock price at filing: $2.39 (July 31, 2026), well below the $25.20 and $13.86 warrant exercise prices, making cash exercise unlikely.
- This is the 13th offering/registration filing in the last 24 months, reflecting persistent capital raising.
- Market cap: $12M; short interest ~4% of estimated shares outstanding.
Financial Impact
Up to ~$3.2M in potential proceeds from cash warrant exercises, but current stock price of $2.39 is far below exercise prices ($25.20 and $13.86), making cash exercise highly unlikely. No new capital raised from the resale itself.
Risk Factors
- Massive warrant overhang (over 3.4M shares) creates persistent dilution risk and selling pressure.
- Going-concern warning signals high risk of equity raise at distressed levels or business failure.
- Stock price ($2.39) far below warrant exercise prices ($25.20, $13.86) makes cash exercise improbable, limiting potential capital infusion.
- 13 offering/registration filings in 24 months indicates chronic capital needs and potential shareholder fatigue.
- Pre-revenue commercial stage with no reported revenue — any dilution is purely dilutive without offsetting earnings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001213900-26-085650 |
| Document: ea029715001ex-fee.htm | 0001213900-26-085650 |
| Document: ea029715001ex5-1.htm | 0001213900-26-085650 |
| Document: ea029715001ex23-1.htm | 0001213900-26-085650 |
| Document: 0001213900-26-085650-index-headers.html | 0001213900-26-085650 |
| Document: 0001213900-26-085650-index.html | 0001213900-26-085650 |
| Document: 0001213900-26-085650.txt | 0001213900-26-085650 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | DEF 14A | $2.08 | awaiting T+60 | — | $1.65 (+20.67%) |
Aug 19, 2026 9w ago | EFFECT | $3.32 | awaiting T+60 | — | $1.65 (+50.30%) |
Aug 5, 2026 11w ago | S-3 | $2.03 | awaiting T+60 | — | $1.65 (+18.72%) |
Apr 23, 2026 26w ago | S-3 | $4.65 $2.64 | ▲ +43.16% | ▲ +48.18% | $1.65 (+64.48%) |
Apr 21, 2026 26w ago | 8-K | $5.00 $3.24 | ▲ +35.20% | ▲ +42.10% | $1.65 (+67.00%) |
Apr 21, 2026 26w ago | 424B5 | $5.00 $3.24 | ▲ +35.20% | ▲ +42.10% | $1.65 (+67.00%) |
Apr 16, 2026 27w ago | 8-K | $4.82 $3.99 | ▼ −17.22% | ▼ −24.27% | $1.65 (−65.77%) |
Mar 4, 2026 33w ago | 424B4 | $5.70 $5.14 | ▲ +9.82% | ▲ +19.91% | $1.65 (+71.05%) |
Mar 4, 2026 33w ago | EFFECT | $5.70 $5.14 | ▼ −9.82% | ▼ −19.91% | $1.65 (−71.05%) |
Feb 27, 2026 34w ago | S-1 | $7.41 $4.90 | ▲ +33.87% | ▲ +43.26% | $1.65 (+77.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers